d2i

Based in the US, d2i provides advanced software services to enhance healthcare analytics, focusing on optimizing emergency and hospital medicine operations for improved patient care and operational efficiency. d2i specializes in healthcare analytics aimed at enhancing operational performance and patient care in emergency and hospital medicine. Founded in 2010 and headquartered in Boonton, US, the company has undergone a significant pivot with its acquisition by ESO Solutions Inc. on April 7, 2026, although specific financial terms were not disclosed.

The company appears to have been founded by a team of individuals with relevant industry expertise, although further details about them are not provided. d2i offers advanced healthcare analytics specifically designed to optimize emergency and hospital medicine operations. The company’s core service, Data as a Service (DaaS), integrates and transforms fragmented clinical, operational, and financial data into actionable insights. This service relies on a longitudinal dataset of over 50 million emergency department and inpatient visit records, with more than 10 million new records added each year.

d2i serves a diverse clientele, including large independent physician groups and healthcare administrators, providing analytics that enhance operational efficiency and clinical performance initiatives primarily within the United States. d2i generates revenue through a subscription-based model for its Data as a Service, with clients paying for access to curated healthcare data and analytics. Contracts are typically structured as annual or multi-year agreements, allowing clients to utilize the platform continuously for insights into operational performance and clinical outcomes. The service supports various healthcare initiatives, including quality improvement and operational efficiency, ensuring that clients receive tailored analytics that reflect their unique environments, although specific pricing details are not disclosed.

Following its acquisition by ESO Solutions Inc. in April 2026, d2i aims to enhance its business development and expand its offerings. The acquisition is expected to support strategic initiatives, although specific upcoming products or market expansions have not been detailed. Going forward, d2i will leverage its enhanced capabilities to continue providing valuable healthcare analytics and explore additional markets.